The major highlight of the Q1 report concerns the usability study conducted in Boston. The objective was to verify the safety of the equipment used to monitor the lungs of preterm born infants and to assess how the neonatal nurses utilized it. Watch CEO Hanna Sjöström and Magnus Johnsson, Head of Quality, discuss the results, the company’s financials, and the next steps towards clinical trials in the BioStock studio.
Watch the Q1 report commentary in the BioStock studio with Hanna Sjöström and Magnus Johnsson below.